Pharmerica (PMC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PharMerica Reports Second Quarter 2016 Results
August 9, 2016 8:02 AM EDTDiversified Pharmacy Businesses Exceeding Managements Expectations
Reaffirms Annual 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2016.
     2Q16 Results ÂComparison to
2Q15
ÂComparison to
1Q16
 Revenue   $519.6 million  Increase of 4.4%  Decrease of 0.9%  Gross profit   $81.8 million  Increase of 0.7%  Decrease of 0.2%  ... MorePharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr.
August 9, 2016 8:02 AM EDTSearch Process Underway to Identify Successor
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that David W. Froesel Jr., Executive Vice President, Chief Financial Officer and Treasurer, intends to retire from the Company. Mr. Froesel will continue as Chief Financial Officer through the end of September 2016 to ensure a seamless transition. PharMerica... More
